PTSD Trauma and Stressor-Related
Some individuals are at a substantially increased risk for mental health problems after mild traumatic brain injury.
Palo Alto Health Sciences announced that the FDA has granted clearance to Freespira, a new digital therapeutic for the treatment of PTSD.
Giving patients with post-traumatic stress disorder (PTSD) their preferred treatment improves adherence and symptoms.
Patients with PTSD should consider concurrent treatment with evidence-based psychotherapy to maximize their chances for meaningful improvement.
This research supports the use of mindfulness-based stress reduction as a treatment method for veterans with PTSD.
The authors argue that these findings suggest that reducing shame among veterans with post-traumatic stress disorder may reduce the risk for suicide.
Acting in the capacity of a surrogate decision maker can lead to emotional distress and poor health-related quality of life.
This initial evidence points toward sex differences among adolescents experiencing PTSD symptoms, both in network connectivity and symptom centrality.
Participants in the prolonged exposure therapy arm experienced greater improvements in PTSD symptom severity from baseline to post-treatment than those receiving supportive counseling.
World Trade Center-related PTSD is a risk factor for myocardial infarction and stroke among workers involved in cleaning up the debris.
Participants in the trial were randomized to receive Tonmya 5.6mg sublingually at bedtime for 12 weeks or placebo sublingual tablets.
Want to read more?
Please login or register first to view this content.
Next post in PTSD trauma and stressor-related